Aleksandra Toloczko
Overview
Explore the profile of Aleksandra Toloczko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Toloczko A, Kazmierczak M, Ksiazek M, Weselski M, Siczek M, Kusz J, et al.
Dalton Trans
. 2024 Apr;
53(16):7163-7174.
PMID: 38573306
Reactions between 1,2-di(tetrazol-2-yl)ethane (ebtz), 1,6-di(tetrazol-2-yl)hexane (hbtz) or 1,1'-di(tetrazol-1-yl)methane (1ditz) and Fe(BF) in the presence of adiponitrile (ADN), glutaronitrile (GLN) or suberonitrile (SUN) resulted in the formation of coordination polymers [Fe(μ-ebtz)(μ-ADN)](BF)...
2.
Kang E, Weir A, Meagher N, Farrington K, Nelson G, Ghatage P, et al.
Cancer
. 2022 Dec;
129(5):697-713.
PMID: 36572991
Background: Cyclin E1 (CCNE1) is a potential predictive marker and therapeutic target in tubo-ovarian high-grade serous carcinoma (HGSC). Smaller studies have revealed unfavorable associations for CCNE1 amplification and CCNE1 overexpression...
3.
Krezel P, Olejniczak T, Toloczko A, Gach J, Weselski M, Bronisz R
Antibiotics (Basel)
. 2022 Nov;
11(11).
PMID: 36358155
The resistance of and other pathogenic yeasts to azole antifungal drugs has increased rapidly in recent years and is a significant problem in clinical therapy. The current state of pharmacological...
4.
Cui T, Fakhfakh K, Turney H, Guler-Gane G, Toloczko A, Hulley M, et al.
Biotechnol Prog
. 2022 Sep;
39(1):e3301.
PMID: 36101497
In recent years, mRNA-based therapeutics have been a fast-growing new class of biologics that can, in principle, encode any protein(s) directly in patients to treat various diseases. mRNA vaccines have...
5.
Ksiazek M, Weselski M, Kazmierczak M, Toloczko A, Siczek M, Durlak P, et al.
Chemistry
. 2020 Jul;
26(63):14419-14434.
PMID: 32678463
Reaction of 1,2-di(tetrazol-2-yl)ethane (ebtz) with Fe(BF ) ⋅6 H O in different nitriles yields one-dimensional coordination polymers [Fe(ebtz) (RCN) ](BF ) ⋅nRCN (n=2 for R=CH (1) and n=0 for R=C...
6.
Ksiazek M, Weselski M, Dreczko A, Maliuzhenko V, Kazmierczak M, Toloczko A, et al.
Dalton Trans
. 2020 Jul;
49(28):9811-9819.
PMID: 32633296
1,4-Di(1-ethyl-1,2,3-triazol-5-yl)butane (bbtre) was prepared by lithiation of 1-ethyl-1,2,3-triazole, followed by alkylation with 1,4-dibromobutane. The ligand bbtre forms a three-dimensional network with Fe(ii), [Fe(bbtre)3](ClO4)2·2CH3CN, that exhibits thermally induced spin crossover (SCO)....
7.
Talhouk A, George J, Wang C, Budden T, Tan T, Chiu D, et al.
Clin Cancer Res
. 2020 Jun;
26(20):5411-5423.
PMID: 32554541
Purpose: Gene expression-based molecular subtypes of high-grade serous tubo-ovarian cancer (HGSOC), demonstrated across multiple studies, may provide improved stratification for molecularly targeted trials. However, evaluation of clinical utility has been...
8.
Trusch F, Loebach L, Wawra S, Durward E, Wuensch A, Iberahim N, et al.
Nat Commun
. 2018 Jun;
9(1):2347.
PMID: 29904064
The animal-pathogenic oomycete Saprolegnia parasitica causes serious losses in aquaculture by infecting and killing freshwater fish. Like plant-pathogenic oomycetes, S. parasitica employs similar infection structures and secretes effector proteins that...
9.
Block M, Vierkant R, Rambau P, Winham S, Wagner P, Traficante N, et al.
Mayo Clin Proc
. 2018 Mar;
93(3):307-320.
PMID: 29502561
Objective: To evaluate myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 (TLR4) expression in relation to clinical features of epithelial ovarian cancer, histologic subtypes, and overall survival....
10.
Goode E, Block M, Kalli K, Vierkant R, Chen W, Fogarty Z, et al.
JAMA Oncol
. 2017 Oct;
3(12):e173290.
PMID: 29049607
Importance: Cytotoxic CD8+ tumor-infiltrating lymphocytes (TILs) participate in immune control of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8+ TILs by histotype and in relation to...